Skip to main content
Top
Published in:

Open Access 24-02-2025 | Glaucoma | Case Report

Successful management with Paul® Glaucoma Drainage Implant after complicated bleb needling with uveal prolapse into the bleb ten years after trabeculectomy

Authors: Ermioni Panidou-Marschelke, Ekaterina Sokolenko, Carsten Framme, Maximilian Binter

Published in: BMC Ophthalmology | Issue 1/2025

Login to get access

Abstract

Background

Fibrosis is the primary cause of failure following glaucoma surgery. Wound healing modulation with 5-fluorouracil and mitomycin-C is routinely employed to reduce ocular fibrosis and improve surgical success rates; however, it also increases the risk of postoperative complications.

Case presentation

A 59-year-old patient with a family history of glaucoma presented a decade after bilateral trabeculectomy with an intraocular pressure (IOP) of 30 mmHg in the right eye and 42 mmHg in the left eye. Both eyes underwent multiple cyclophotocoagulations in the past and showed ocular surface inflammation due to eyedrop intolerance as well as scarred blebs without scleral thinning. Simultaneous bilateral bleb needling reduced IOP to 7 mmHg on the right eye and 12 mmHg on the left eye. The postoperative course of the right eye was favorable with a stable IOP at the low teens. However, IOP of the left eye rose to 34 mmHg within 3 days, accompanied by a uveal prolapse into the bleb. A subsequent vitrectomy with Tutopatch® and anterior chamber washout was performed after 10 days, followed by implantation of the novel Paul® Glaucoma Drainage Implant after sufficient scleral healing. This resulted in a postoperative IOP of 8 mmHg. After 12 months, no eyedrops were required, there were no signs of ocular surface inflammation, and the IOP was stable at 13 mmHg in the right eye and 12 mmHg in the left eye.

Conclusion

This case highlights a rare occasion of scleral thinning leading to perforation with uveal prolapse after needling, 10 years post-trabeculectomy. Likely causes include the use of antimetabolites, cyclodestructive procedures, and chronic conjunctival inflammation from eyedrops. Although needling is typically low-risk, it can lead to complications similar to trabeculectomy. Preoperative screening for scleral thinning using slit lamp and anterior segment OCT is recommended for high-risk patients. The presented two-stage treatment strategy proved successful in managing this complex case.
Literature
1.
go back to reference Jonas JB, Aung T, Bourne RR, Bron AM, Ritch R, Panda-Jonas S. Glaucoma Lancet. 2017;390(10108):2183–93.CrossRefPubMed Jonas JB, Aung T, Bourne RR, Bron AM, Ritch R, Panda-Jonas S. Glaucoma Lancet. 2017;390(10108):2183–93.CrossRefPubMed
2.
go back to reference Aspberg J, Heijl A, Bengtsson B. Screening for open-angle glaucoma and its effect on blindness. Am J Ophthalmol. 2021;228:106–16.CrossRefPubMed Aspberg J, Heijl A, Bengtsson B. Screening for open-angle glaucoma and its effect on blindness. Am J Ophthalmol. 2021;228:106–16.CrossRefPubMed
3.
go back to reference European Glaucoma Society. Terminology and guidelines for glaucoma, 5th edition. Br J Ophthalmol. 2021;105(Suppl 1):1–169.CrossRef European Glaucoma Society. Terminology and guidelines for glaucoma, 5th edition. Br J Ophthalmol. 2021;105(Suppl 1):1–169.CrossRef
4.
5.
go back to reference Kavitha S, Tejaswini SU, Venkatesh R, Zebardast N. Wound modulation in glaucoma surgery: the role of anti-scarring agents. Indian J Ophthalmol. 2024;72(3):320–7.CrossRefPubMed Kavitha S, Tejaswini SU, Venkatesh R, Zebardast N. Wound modulation in glaucoma surgery: the role of anti-scarring agents. Indian J Ophthalmol. 2024;72(3):320–7.CrossRefPubMed
7.
go back to reference Lin S, Byles D, Smith M. Long-term outcome of mitomycin C-augmented needle revision of trabeculectomy blebs for late trabeculectomy failure. Eye (Lond). 2018;32(12):1893–9.CrossRefPubMed Lin S, Byles D, Smith M. Long-term outcome of mitomycin C-augmented needle revision of trabeculectomy blebs for late trabeculectomy failure. Eye (Lond). 2018;32(12):1893–9.CrossRefPubMed
8.
go back to reference Kapasi MS, Birt CM. The efficacy of 5-fluorouracil bleb needling performed 1 year or more post-trabeculectomy: a retrospective study. J Glaucoma. 2009;18(2):144–8.CrossRefPubMed Kapasi MS, Birt CM. The efficacy of 5-fluorouracil bleb needling performed 1 year or more post-trabeculectomy: a retrospective study. J Glaucoma. 2009;18(2):144–8.CrossRefPubMed
9.
go back to reference Tan MCJ, Choy HYC, Koh TCV, Aquino MC, Sng CCA, Lim DK, et al. Two-year outcomes of the Paul Glaucoma Implant for treatment of glaucoma. J Glaucoma. 2022;31(6):449–55.CrossRefPubMedPubMedCentral Tan MCJ, Choy HYC, Koh TCV, Aquino MC, Sng CCA, Lim DK, et al. Two-year outcomes of the Paul Glaucoma Implant for treatment of glaucoma. J Glaucoma. 2022;31(6):449–55.CrossRefPubMedPubMedCentral
10.
go back to reference Koh V, Chew P, Triolo G, Lim KS, Barton K, PAUL Glaucoma Implant Study Group. Treatment outcomes using the PAUL Glaucoma Implant to control intraocular pressure in eyes with refractory glaucoma. Ophthalmol Glaucoma. 2020;3(5):350–9.CrossRefPubMed Koh V, Chew P, Triolo G, Lim KS, Barton K, PAUL Glaucoma Implant Study Group. Treatment outcomes using the PAUL Glaucoma Implant to control intraocular pressure in eyes with refractory glaucoma. Ophthalmol Glaucoma. 2020;3(5):350–9.CrossRefPubMed
11.
go back to reference Weber C, Hundertmark S, Stasik I, Holz FG, Mercieca K. Two-year clinical outcomes of the PAUL Glaucoma Implant in white patients with refractory glaucoma. J Glaucoma. 2024;33(10):808–14.CrossRefPubMed Weber C, Hundertmark S, Stasik I, Holz FG, Mercieca K. Two-year clinical outcomes of the PAUL Glaucoma Implant in white patients with refractory glaucoma. J Glaucoma. 2024;33(10):808–14.CrossRefPubMed
12.
go back to reference Paczka JA, Ponce-Horta AM, Tornero-Jimenez A. Acute attack of glaucoma after scleral melting and iris blockage of the surgical ostium: a case report of a complication derived from a mitomycin C supplemented trabeculectomy. J Curr Glaucoma Pract. 2022;16(3):199–204.CrossRefPubMedPubMedCentral Paczka JA, Ponce-Horta AM, Tornero-Jimenez A. Acute attack of glaucoma after scleral melting and iris blockage of the surgical ostium: a case report of a complication derived from a mitomycin C supplemented trabeculectomy. J Curr Glaucoma Pract. 2022;16(3):199–204.CrossRefPubMedPubMedCentral
14.
go back to reference Sabri K, Vernon SA. Scleral perforation following trans-scleral cyclodiode. Br J Ophthalmol. 1999;83(4):502–3.CrossRefPubMed Sabri K, Vernon SA. Scleral perforation following trans-scleral cyclodiode. Br J Ophthalmol. 1999;83(4):502–3.CrossRefPubMed
15.
go back to reference Hamanaka T, Omata T, Sekimoto S, Sugiyama T, Fujikoshi Y. Bleb analysis by using anterior segment optical coherence tomography in two different methods of trabeculectomy. Invest Ophthalmol Vis Sci. 2013;54(10):6536–41.CrossRefPubMed Hamanaka T, Omata T, Sekimoto S, Sugiyama T, Fujikoshi Y. Bleb analysis by using anterior segment optical coherence tomography in two different methods of trabeculectomy. Invest Ophthalmol Vis Sci. 2013;54(10):6536–41.CrossRefPubMed
16.
go back to reference Christakis PG, Kalenak JW, Zurakowski D, Tsai JC, Kammer JA, Harasymowycz PJ, et al. The Ahmed Versus Baerveldt study: one-year treatment outcomes. Ophthalmology. 2011;118(11):2180–9.CrossRefPubMed Christakis PG, Kalenak JW, Zurakowski D, Tsai JC, Kammer JA, Harasymowycz PJ, et al. The Ahmed Versus Baerveldt study: one-year treatment outcomes. Ophthalmology. 2011;118(11):2180–9.CrossRefPubMed
17.
go back to reference Choritz L, Koynov K, Renieri G, et al. Surface topographies of glaucoma drainage devices and their influence on human Tenon fibroblast adhesion. Invest Ophthalmol Vis Sci. 2010;51:4047–53.CrossRefPubMed Choritz L, Koynov K, Renieri G, et al. Surface topographies of glaucoma drainage devices and their influence on human Tenon fibroblast adhesion. Invest Ophthalmol Vis Sci. 2010;51:4047–53.CrossRefPubMed
18.
go back to reference Vallabh NA, Mohindra R, Drysdale E, Mason F, Fenerty CH, Yau K. The PAUL® glaucoma implant: 1-year results of a novel glaucoma drainage device in a pediatric cohort. Graefes Arch Clin Exp Ophthalmol. 2023;261(8):2351–8.CrossRefPubMed Vallabh NA, Mohindra R, Drysdale E, Mason F, Fenerty CH, Yau K. The PAUL® glaucoma implant: 1-year results of a novel glaucoma drainage device in a pediatric cohort. Graefes Arch Clin Exp Ophthalmol. 2023;261(8):2351–8.CrossRefPubMed
19.
go back to reference Berteloot S, Correia Barão R, Abegão Pinto L, Vandewalle E, Stalmans I, Lemmens S. Treatment outcomes comparing the Paul and Baerveldt glaucoma implants after one year of follow-up. J Glaucoma. 2024;33(8):594–600.CrossRefPubMedPubMedCentral Berteloot S, Correia Barão R, Abegão Pinto L, Vandewalle E, Stalmans I, Lemmens S. Treatment outcomes comparing the Paul and Baerveldt glaucoma implants after one year of follow-up. J Glaucoma. 2024;33(8):594–600.CrossRefPubMedPubMedCentral
20.
go back to reference Tan MCJ, Ong CW, Aquino MC, Lun KW, Sng CCA, Lim DK, et al. Three-year outcomes of the Paul Glaucoma Implant for treatment of glaucoma. J Glaucoma. 2024;33(7):478–85.CrossRefPubMedPubMedCentral Tan MCJ, Ong CW, Aquino MC, Lun KW, Sng CCA, Lim DK, et al. Three-year outcomes of the Paul Glaucoma Implant for treatment of glaucoma. J Glaucoma. 2024;33(7):478–85.CrossRefPubMedPubMedCentral
Metadata
Title
Successful management with Paul® Glaucoma Drainage Implant after complicated bleb needling with uveal prolapse into the bleb ten years after trabeculectomy
Authors
Ermioni Panidou-Marschelke
Ekaterina Sokolenko
Carsten Framme
Maximilian Binter
Publication date
24-02-2025
Publisher
BioMed Central
Published in
BMC Ophthalmology / Issue 1/2025
Electronic ISSN: 1471-2415
DOI
https://doi.org/10.1186/s12886-025-03906-2